Market LIVE
Published markets; coverage varies by country
Product profile · United States

BIJUVA

 ·  Patent Litigation & Settlement History ↓

IngredientESTRADIOL; PROGESTERONE
Application typeNDA
Application210132
Product002
Dosage formCAPSULE
RouteORAL
Strength0.5MG;100MG
Approval date2021-12-28
Marketing statusPrescription
Status event—
ApplicantMAYNE PHARMA
Product source

Current GenericRadar decision

Year2021
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeAPPROVAL_YEAR_FALLBACK
Anchor date2021-12-28
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

APPROVAL_YEAR_FALLBACK

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
100523862032-11-21DP —NNDP
———
102069322032-11-21U U-2439NNU
———
106752882032-11-21U U-2439NNU
———
110336262032-11-21DP/U U-2439NNDP
———
111669632032-11-21DP —NNDP
———
117938192032-11-21U U-2439NNU
———
118651792032-11-21DS/DP —NNDP
———
86331782032-11-21DP —NNDP
———
88466482032-11-21U U-2439NNU
———
88466492032-11-21DP/U U-2439NNDP
———
89330592032-11-21DP/U U-2439NNDP
———
89872372032-11-21DP —NNDP
———
89935482032-11-21DP —NNDP
———
89935492032-11-21DP —NNDP
———
91141452032-11-21U U-2439NNU
———
91141462032-11-21DP/U U-2439NNDP
———
93019202032-11-21DP/U U-2439NNDP
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
REGULATORY_STATUS2021-12-28CANONICAL_DECISIONAPPROVAL_YEAR_FALLBACKSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.